mandrake, and black henbane. 3 -10 Anticholinergic symptoms generally begin within 1 h of ingestion and may continue for days. Severe toxicity results in agitation, hallucinations, hyperthermia, tachycardia, rhabdomyolysis, renal failure, and death. 4 , 11 -13 Without aggressive supportive care, death can result from rhabdomyolysis-induced renal failure, disseminated intravascular coagulation, dysrhythmias, or uncontrolled seizures. Sedation with benzodiazepines may be required to control hyperthermia and rhabdomyolysis. In the absence of contraindications (eg, history of seizures or the presence of intraventricular conduction delay, bronchospasm, or impaired atrioventricular nodal conduction), physostigmine can be used. It should be noted that duration of the anticholinergic effects can outlast the effects of the physostigmine, making redosing occasionally necessary.
Nicotine Alkaloids
Nicotine alkaloids that activate and then block acetylcholine nicotinic receptors are found in tobacco species, betel nut, and poison hemlock. 14 -16 Patients commonly experience paresthesias, nausea, and vomiting. More severe cases progress to generalized seizures, autonomic instability, salivation, bronchospasm, and bronchorrhea. 17 -22 Symptoms typically commence 15 to 60 min postexposure. Seizures are best treated with benzodiazepines, whereas symptomatic bradycardia, bronchospasm, or bronchorrhea are treated with atropine. 23 Indole compounds capable of producing hallucinations through activation of 5-HT 2 receptors are found in morning glory and Hawaiian baby woodrose. 24 , 25 Nutmeg 26 and peyote contain compounds that structurally resemble amphetamines yet also interact with serotonin receptors. 27 Illness usually begins with vomiting followed by hallucinations. Profound mydriasis is common and agitation, tachycardia, and rhabdomyolysis can also occur. Agitation is best treated with benzodiazepines. The differential diagnosis for poisoning by these plants includes poisoning by anticholinergic botanicals, with axillary anhydrosis suggesting anticholinergic toxicity.
Toxicology in the ICU

Water Hemlocks/Dropworts
Plants of the genera Cicuta and Oenanthe contain complex alcohols (eg, cicutoxin) that antagonize g aminobutyric acid-A (GABA-A) receptors. 23 , 28 These plants grow near water and can be mistaken for wild parsley or carrots. Ingestion is associated with a high mortality rate 26 and can produce sudden onset of vomiting and seizure. 23 Seizures should be treated with benzodiazepines or barbiturates. Rhabdomyolysis is also possible.
Strychnine
Strychnine toxicity can occur from consuming contents of the strychnine tree. However, in North America, toxicity is most likely encountered following exposure to strychnine-containing rodenticides or following use of strychnine-contaminated heroin. Strychnine's antagonism of the glycine receptors in the CNS produces hyperrefl exia, rigidity, and opisthotonus. 29 Minimal stimulation can elicit muscle contraction and rigidity, but true seizures are not typically encountered. The diffuse excessive motor activity, often mistaken for seizures, occurs in patients with a clear sensorium. Prolonged muscular contractions can lead to rhabdomyolysis, renal failure, respiratory failure, and death. 30 In patients refractory to benzodiazepines, nondepolarizing neuromuscular blockade and mechanical ventilation may be required. 29 
Cardiac Glycosides
Cardiac glycosides are found in several species, including foxglove, common oleander, yellow oleander, and lily of the valley. 31 , 32 The illness resulting from ingestion of these plants is identical to that of acute digoxin poisoning. Vomiting, bradycardia and/or atrioventricular blocks, and increased automaticity can occur. The degree of hyperkalemia correlates with mortality. 33 , 34 Serum digoxin levels measured by immunoassays may be elevated from cross-reaction with various glycosides similar to digoxin, 33 , 35 although the reported serum digoxin concentration will not necessarily correlate with toxicity. Digoxin-immune Fab fragments should be administered for the same indications as digoxin poisoning, namely life-threatening dysrhythmias or hyperkalemia. 36 Higher doses may be required for treatment of botanical-induced cardiac glycoside toxicity. 37 
Sodium Channel Openers
Aconitine from monkshood, veratrum alkaloids from hellebores, and grayanotoxins from rhododendrons open voltage-gated sodium channels or prevent sodium channel inactivation. 38 -42 The resultant rise in intracellular sodium concentration produces increased vagal tone and automaticity, which resembles cardiac glycoside toxicity, but without hyperkalemia. Veratrum alkaloids and grayanotoxins mainly produce sinus bradycardia and heart blocks with resultant hypotension and syncope. 43 , 44 Paresthesias and vomiting are also possible. Atropine is usually successful in restoring normal heart rhythm and BP.
In contrast, aconitine poisoning carries the highest mortality and is more likely to produce tachydysrhythmias, including torsade de pointes. 45 Various antidysrhythmic drugs have anecdotally been reported in treatment of aconite-induced ventricular dysrhythmias, including amiodarone and magnesium.
Sodium Channel Antagonists
Taxines, as found in the yew, are alkaloids that inhibit sodium and calcium transport across cell membranes. Following ingestion, intraventricular conduction delays, hypotension, and ventricular dysrhythmias may result. 46 Primary treatment is supportive care.
Animal data failed to demonstrate benefi t from hypertonic sodium bicarbonate, 47 although a single case report described narrowing of the QRS complex with sodium bicarbonate. 48 
Pyrrolizidine Alkaloids
Various species contain a collection of hepatotoxic pyrrolizidine alkaloids, including groundsel and comfrey. 49 These botanicals are often ingested as herbal preparations, commonly in the form of tea. The alkaloids undergo hepatic metabolism to pyrroles that serve as alkylating compounds. 50 Acute ingestions produce acute liver failure with centrilobular necrosis. In contrast, hepatotoxicity from chronic ingestion is characterized by hepatic microvenoocclusive disease with hepatomegaly, ascites, and jaundice. 49 , 50 N-acetylcysteine may be benefi cial if administered early. 51 Numerous plants contain cyanide glycosides, such as amygdalin, that following ingestion are cleaved by glucosidases to release hydrogen cyanide. 52 Toxicity can result from ingestion of pits from apricots or peaches or from amygdalin purchased as a nutritional supplement. 52 -54 After a latency period of minutes to hours, the clinical fi ndings and management are identical to cyanide toxicity due to other causes. 52 The reader is referred to the second part of this series for a discussion on cyanide toxicity. 36 
Antimitotic Agents
Colchicine and podophyllotoxin affect microtubule formation to interfere with cellular function and division. Ingestions produce gastroenteritis and abdominal pain followed by multiple organ system failure and death over hours to days. 55 , 56 An initial leukocytosis is followed by leukopenia or pancytopenia. Podophyllotoxin is more likely to produce neurotoxicity early, but both groups of toxins can cause coma. Furthermore, rhabdomyolysis, cardiomyopathy, and alopecia can occur with both. Death, if it occurs, is due to either cardiovascular collapse or sepsis, with the latter typically occurring several days later, as a result of pancytopenia from bone marrow suppression. Treatment is supportive and may include granulocyte colony-stimulating factor once pancytopenia develops. 57 
Ackee Poisoning
The unripe ackee fruit contains the toxin hypoglycin A which inhibits b oxidation of fatty acids. 58 , 59 Ingestion of unripe fruit leads to hepatic microvesicular steatosis, hyperammonemia, metabolic acidosis, hypoglycemia, and secondary carnitine depletion. 58 Vomiting, abdominal pain, hypotonia, seizures, and coma are observed. 58 , 60 , 61 In addition to supportive care and correction of hypoglycemia, therapy focuses on providing adequate calories in the form of carbohydrates and possibly the administration of levocarnitine.
Mushrooms
Mushroom poisoning frequently occurs following misidentifi cation of toxic mushrooms as edible species and is responsible for numerous fatalities annually worldwide. 62 , 63 Table 2 64 -77 summarizes the major syndromes. The following discussion emphasizes those most likely to result in admission to an ICU in North America. In general, if the onset of gastrointestinal symptoms occurs . 6 h postingestion the concern for ingestion of hepatotoxic or seizurogenic mushrooms rises. Early vomiting makes sys temic toxicity unlikely, with the exception of allenic norleucinecontaining mushrooms. 62 , 63 Ingestion of more than one type of mushroom makes the above rule unreliable.
Cyclopeptides
Amanita phalloides , Lepiota species, and Galerina species contain amatoxin, which inhibits protein synthesis. 63 , 78 An asymptomatic latency of . 6 h usually precedes gastroenteritis. Hepatic failure develops within several days. Encephalopathy and convulsions are common in severe cases. 62 , 63 Histologically, fatty degeneration and centrilobular hepatic necrosis are observed. 79 Despite recommendations for various therapies, none have been examined in well-designed trials. Enterohepatic recirculation of amatoxin might be reduced by the use of a dose of activated charcoal. 64 The early administration of high-dose IV penicillin (1,000,000 units/kg ) may be protective, although data are confl icting. 65 , 66 IV N-acetylcysteine is often administered without consistent evidence. 63 , 78 , 79 Silibinin from the milk thistle plant is commonly used in Europe but has been ineffective in at least some animal studies. 63 , 65 , 78 , 80 Liver transplantation may ultimately be required. 81 , 82 Gyromitrin Ingestion of Gyromitra species (false morels) results in gastroenteritis beginning several hours postingestion. 83 Monomethylhydrazine inhibits pyridoxal kinase in a manner similar to isoniazid to produce generalized seizures that respond to IV pyridoxine (5 g IV for an adult). 68 Hemolytic anemia and methemoglobinemia may also develop. 63 
Muscimol/Ibotenic Acid
Amanita muscaria (fl y agaric), Amanita pantherina (panther), and other mushrooms contain muscimol, an agonist at g aminobutyric acid-A receptors, and ibotenic acid, an agonist of glutamate receptors. 63 , 67 Ibotenic acid also undergoes decarboxylation to muscimol. Symptoms typically develop shortly after ingestion and include nausea and vomiting and CNS depression or stimulation, depending on the concentrations of ibotenic acid and muscimol. Seizures, ataxia, hallucinations, or somnolence can occur. 63 , 67 , 84 , 85 Treatment is supportive.
Nephrotoxins
Orellanine is a nephrotoxic compound found in Cortinarius orellanus and several other species. 63 , 65 , 68 Following a latency period of up to 3 weeks, patients 65 , 68 Treatment may require hemodialysis, with almost half of those requiring early dialysis developing chronic renal failure. 63 In the northwestern United States, ingestion of Amanita smithiana or Amanita abrupta , which contain allenic norleucine, has produced early gastrointestinal symptoms followed by renal failure several days later. 63 Hemodialysis is often required. The potential for early-onset gastroenteritis is an important exception to the general rule that more serious mushroom poisoning results in delayed GI symptoms. 
Miscellaneous
Hallucinogenic mushrooms, including Psilocybe species, contain an indole hallucinogen. The illness is rarely life threatening and treatment is supportive. 86 Coprinus (inky caps) and Boletus species contain a toxin that inhibits acetaldehyde dehydrogenase. Although co-ingestion of alcohol with the mushrooms usually is tolerated without problems, the ingestion of alcohol hours to days later results in disulfi ram-like reactions, with fl ushing, diaphoresis, vomiting, headache, and tachycardia. The illness is usually mild and treatment is supportive. 87 
Metals
Lead
Although the overall prevalence of lead toxicity is declining, this condition remains an important health concern throughout the United States and worldwide. Most cases of lead toxicity result from chronic toxicity, rather than single acute ingestion. Single, acute toxic lead ingestions are rare, but can result in diarrhea, hemolysis, hepatic necrosis, encephalopathy, and renal failure. 88 More commonly, patients present with relatively acute onset of signs and symptoms from previously unrecognized chronic lead poisoning. 89 For example, the ingestion of elemental lead objects (eg, curtain weights), can cause delayed, life-threatening poisoning. 88 Chronic poisoning can produce anemia, abdominal pain, malaise, renal failure, and encephalopathy. 90 -94 Radiographs in children may demonstrate "lead lines" in bones, which represent areas of increased calcium density, not lead deposition. Retained bullets do not produce lead poisoning unless fragments are in prolonged contact with synovial fl uid, pleural fl uid, or cerebrospinal fl uid. 95 -98 When evaluating patients for lead toxicity, a capillary blood concentration can be used only for screening but is notoriously inaccurate and should not be used for treatment decisions. Only whole blood lead concentrations should be used when deciding on a management strategy. In situations in which chronicity is not able to be established, free erythrocytic protoporphyrin (FEP) and zinc protoporphyrin (ZPP) concentrations can be helpful. Chronic toxicity will have elevated FEP and ZPP, whereas acute toxicity will have normal FEP and ZPP. 99 The ideal therapy involves interpreting the patient's whole blood lead concentration in context with the patient's age and clinical symptoms. The Centers for Disease Control and Prevention publishes guidelines to assist in deciding appropriate treatment of these patients. In asymptomatic patients with only moderately elevated lead concentration, chelation is not necessarily recommended. For cases in which chelation is recommended, however, 2, 3-mesodimercaptosuccinic acid (succimer), or dimercaprol and calcium disodium ethylene diamine tetraacetic acid may be used. 93 , 100 Treatment of Lead Encephalopathy: In addition to sup portive care (eg, benzodiazepines or barbiturates for convulsions, treatment of intracranial hypertension), chelation therapy is usually begun with dimercaprol 75 mg/m 2 deep intramuscular injection every 4 h for 5 days. At least 4 h following administration of dimercaprol, calcium disodium ethylene diamine tetraacetic acid 1,500 mg/m 2 IV per day (continuous infusion or over two to four divided doses) should be commenced, and continued for at least 5 days. 96 Nephrotoxicity can occur as a result of the chelators. 101 
Iron
Although packaging laws have reduced the incidence of accidental ingestions of iron in children, 102 acute iron toxicity remains a common problem in both adults and children. 1 Iron exists in many formulations, with ferrous fumarate, sulfate, and gluconate being three of the most common preparations. These ferrous salts contain 33%, 20%, and 12% elemental iron, respectively. The risk for acute toxicity of iron correlates with the amount of elemental iron ingested. Signifi cant, life-threatening toxicity is unlikely with ingestions , 60 mg/kg, 103 but histories of amounts ingested are commonly inaccurate.
Following acute ingestion, iron absorption occurs via receptor-dependent and receptor-independent processes. 104 Toxicity is classically described as occurring in four stages. The fi rst stage occurs within 6 h of ingestion and is characterized by vomiting, diarrhea, and abdominal pain. 105 Stage II is classically described as a quiescent period due to resolution of gastrointestinal illness, although metabolic acidosis can progress. Stage III is characterized by multisystem organ failure. 105 Patients who survive stage III may develop bowel obstructions or gastric outlet obstruction (stage IV). 104 The decision to start therapy should be based on the clinical and metabolic fi ndings and not strictly based on the serum iron concentration. 105 Patients should fi rst undergo aggressive crystalloid fl uid resus citation. Patients with signifi cant symptoms, includ ing repeated vomiting or diarrhea, CNS depression, metabolic acidosis, or hypotension should undergo chelation with IV deferoxamine mesylate. Although outcome data on whole bowel irrigation are lacking, its use can be considered in signifi cant iron ingestions. 106 
North American Arthropods
Bark Scorpion (Centruroides sculpturatus)
In North America, Centruroides sculpturatus is the only species that produces systemic human toxicity. 107 The venom consists of neurotoxins that prevent sodium channel inactivation leading to repetitive axonal fi ring. 107 , 108 The clinical effects of cholinergic, adrenergic, and neuromuscular fi ndings are graded on a scale ( Table 3 ) . 107 , 109 Following envenomation, immediate onset of painful burning and paresthesias in the affected area is common. 109 Severe cases advance to cranial nerve dysfunctions, including opsoclonus, tongue fasciculations, hypersalivation, thrashing, and loss of pharyngeal muscle control. 107 , 109 Emesis is typically self-limited, but aspiration and diffi culties with oral secretions are possible.
Supportive care is the cornerstone of treatment. Most patients with low-grade envenomations respond to analgesics alone. Those patients with high-grade envenomations may benefi t from short-acting parenteral opioids (eg, fentanyl 1-2 m g/kg) and sedative hypnotics (eg, midazolam 0.01-0.05 mg/kg). 107 , 108 Atropine can be used to help control signifi cant hypersalivation. 110 , 111 However, the hypersalivation that is observed is typically transient; repeated doses of atropine are unlikely to be benefi cial and have the potential to cause anticholinergic toxicity. Deaths rarely occur because of advancements in supportive care. However, they may result from respiratory failure. Loss of airway protection is particularly problematic in children who manifest hypersalivation and pharyngeal motor dysfunction. Endotracheal intubation may be required. A polyvalent F(ab 9 ) 2 antivenom is currently used successfully in both the United States and Mexico. 112 Without antivenom, severe symptoms may persist for 24 h.
Spiders
Although there are nearly 42,000 spider species worldwide, 113 the vast majority of envenomations in the United States are benign because of short fang length, insuffi cient venom volume, or lack of physiologic human effect. Defi nitive diagnosis of envenomation typically requires both a witnessed bite and a properly identifi ed species known to cause the observed syndrome. 114 Brown Recluse (Loxosceles reclusa): Loxosceles reclusa is a small brown spider that is generally active at night and only bites defensively. 108 , 115 , 116 Figure 1 117 demonstrates a geographical distribution of spiders in the Loxosceles genus. Hyaluronidase and sphingomyelinase D are primary components of the venom. These result in prostaglandin release, acti vation of complement, platelet aggregation, and enhanced neutrophil chemotaxis. 108 , 114 -116 Enzyme-linked immunosorbent assays of wound toxin have been studied but are not readily available. 115 , 118 Most envenomations are self-limited, but clinical effects range from local erythema to large ulcerative lesions. 114 Sharp, burning pain begins within several hours. Dermal lesions progresses over days to form a central, hemorrhagic area that degrades to necrosis and ulceration. 108 , 114 , 115 The resulting eschar may dehisce and take several weeks to heal. Early surgical interventions following the formation of necrosis are unlikely to affect outcome. 116 Viscerocutaneous loxoscelism occurs in , 1% of cases and is characterized by arthralgias, fever, vomiting and diarrhea, rhabdomyolysis, and hemolysis. 114 , 116 Although rare, fatalities are usually related to cardiovascular collapse and hemolysis. 115 Although treatment is conservative, it is imperative to not misdiagnose an alternative condition (eg, skin infection, granulomatous disease, autoimmune skin lesion, and so forth) as Loxosceles envenomation. Furthermore, it is important to realize that not all necrotic skin lesions, including those associated with an arthropod envenomation, are caused by the brown recluse. Other arthropod species can cause dermonecrotic lesions. 114 , 116 In addition, many necrotic skin lesions are incorrectly attributed to arthropods. One such example involves the hobo spider ( Tegenaria agrestis ) in the Pacifi c Northwest. 118 , 119 Treatment is largely supportive. Early surgical excision is contraindicated, but delayed debridement or grafting may be required depending on cosmetic outcome. 108 , 114 , 116 Close outpatient follow-up for wound progression is recommended. 108 Dapsone, corticosteroids, prophylactic antibiotics, hyperbaric oxygen, vasodilators, colchicine, and antihistamines lack supporting data and are not indicated.
Black Widow (Latrodectus mactans): Of the many widow spiders species worldwide, Latrodectus mactans is the most clinically signifi cant in North America. 120 a -Latrotoxin results in diffuse neurotransmitter release, including acetylcholine and norepinephrine. 114 , 120 , 121 The initial bite is usually painful, and presence of a "target lesion" is a fairly reliable indicator of widow envenomation. 121 This lesion is characterized by a central area of pallor surrounded by erythematous rings, resembling a target. Twenty-fi ve percent of envenomations progress to a systemic syndrome of latrodectism within 2 h. Latrodectism consists of severe pain and muscle spasms involving the back, abdomen, and chest, which may wax and wane. Hypertension, tachycardia, and diaphoresis are commonly seen. The muscle spasms and diaphoresis can be diffuse or localized to the site of the bite. 114 , 121 Other effects include fever, priapism, paresthesias, fasciculations, and agitation. 114 , 121 Acute cardiomyopathy complicated by pulmonary edema has been reported. 122 No Latrodectus -related deaths have been reported to US poison centers in several decades. 123 Treatment consists of supportive care, with titration of opioids and benzodiazepines. 114 , 121 Calcium gluconate is not benefi cial and is not recommended. 121 A whole IgG antivenom is available but can lead to immediate or delayed (serum sickness) allergic reactions. 118 Discussion with a medical toxicologist is recommended prior to using antivenom.
Bees and Wasps (Order Hymenoptera)
Honeybee and wasp stings may cause severe allergic reaction, but toxicity is generally limited to massive envenomations involving hundreds of stings. Envenomation preferentially occurs about the head and neck, with intraoral stings being common. 124 Honey bees have a barbed stinger that remains in tissue leading to evisceration after a single sting, whereas wasps are capable of stinging repeatedly. Both species contain similar toxins with similar clinical syndromes. Melittin and phospholipase A 2 are the primary venom toxins, with phospholipase A 2 being the major allergen. 124 , 125 Excluding an immediate anaphylactic reaction, most envenomations are limited to local cutaneous reactions with erythema, pruritus, edema, and pain. Systemic reactions after massive envenomation may include emesis, diarrhea, fever, and myalgias. Significant third-spacing edema with hypotension or shock can occur. Coagulopathy, transaminitis, rhabdomyolysis, and hemolysis may develop within hours. 124 , 126 Clinically, the symptoms observed with massive envenomation may resemble an IgE-mediated anaphylactic event. However, unlike a patient with an anaphylactic event, the patient with a massive envenomation may develop delayed toxicity over the fi rst 24 h.
Treatment is supportive with IV fl uids, systemic steroids, antihistamines, and analgesics. Retained stings may be removed but should not be the focus of initial management as the timing of removal does not change outcome. 127 All patients with evidence of systemic envenomation, signifi cant comorbidities, . 50 stings (adult), or more than two stings per kilogram (children) should be evaluated for admission. Serial laboratory studies, including creatinine kinase, electrolytes, renal function, coagulation studies, and electrocardiograms, should be followed during the fi rst 24 h. Cardiac enzymes should be obtained in critically ill individuals. Patients with evidence of systemic toxicity should receive parenteral antihistamines and steroids.
North American Snakes
Nearly 5,000 patients present to EDs each year with venomous snake bites; many of these patients are admitted to ICUs. 128 Although the diagnosis is more common in southern and rural areas, bites may occur in any city or state, partly due to the practice of keeping venomous snakes as pets.
Most envenomations in the United States follow encounters with pit vipers, which include rattlesnakes, copperheads, and cottonmouths. Rattlesnakes account for roughly one-half of reported pit viper envenomations and are responsible for the greatest morbidity and mortality due to native snake envenomation. Coral snakes and a variety of nonnative venomous snake species cause , 5% of envenomations. 1 Approximately 25% of pit viper bites result in no venom deposition. In the remainder, venom is usually deposited subcutaneously, resulting in a wide spectrum of clinical severity ranging from mild local effects, which resolve quickly, to immediate systemic toxicity and death. Where one falls on the spectrum is largely infl uenced by venom load and potency. 129 Venom contains proteins that may possess cytotoxic, hemotoxic, neurotoxic, and/or myotoxic properties. 130 , 131 Clinically important components in native venoms are those that destroy tissue, produce capillary permeability and edema, inhibit platelets and fi brinogen, and produce anaphylactoid reactions and neurotoxicity.
Following envenomation, edema and pain typically develop within minutes to a few hours, although onset may be delayed, particularly in lower extremity bites. Puncture wounds are visible and hemorrhagic bullae may develop within hours and progress for days. As venom is absorbed via lymphatics, edema increases and tenderness of proximal lymph nodes develops. Tachycardia, vomiting, paresthesias, fasciculations, diarrhea, and hypotension may occur. Although some symptoms may be related to anxiety, early systemic symptoms should alert the clinician to the possibility of a severe envenomation, which may progress quickly or herald an anaphylactoid response to venom, with pending oropharyngeal angioedema or shock. True anaphylaxis may also occur in patients with preformed IgE antibodies against venom proteins. When neurotoxic effects occur, they often include only fasciculations or paresthesias, but some patients bitten by Mojave rattlesnakes may develop ptosis, weakness, and respiratory failure. Although very uncommon, patients may develop life-threatening bleeding. Rarely, true disseminated intravascular coagulation has occurred and has been associated with direct intravascular injection of venom. 129 , 132 Any patient presenting with signs of envenomation should be admitted to the hospital. Patients without swelling should be observed at least 8 h, since even swelling that is delayed in onset may become signifi cant. Some experts opt to admit all children with leg bites for overnight observation regardless of presence of swelling. Constrictive dressings are not recommended, and if placed in the fi eld, should be removed immediately. Prophylactic antibiotics are not indicated. The bitten extremity may be immobilized with a posterior splint and placed in near full extension to avoid increased edema and pain at the joint fl exure. The extremity should be elevated as much as possible to avoid dependent edema, and the circumference monitored frequently (at least every 30-60 min) to determine if swelling is progressing.
All patients should receive IV fl uid boluses and have their tetanus vaccine updated, if warranted based on the vaccination history. Hemoconcentration and intravascular hypovolemia are common because of venom-induced capillary permeability. Treatment of hypotension may require many boluses of crystalloid. If blood pressure does not respond rapidly, an epinephrine infusion should be initiated. Patients with anaphylactoid reactions resulting in angioedema or those with bites to the head or neck should be intubated at the fi rst sign of facial, tongue, or airway swelling. Hypersensitivity reactions are treated with steroids, antihistamines, and epinephrine.
Hematotoxicity is most common following rattlesnake envenomation, but may occur with any native pit viper envenomation. Initial laboratory studies should include a complete blood count, fi brinogen, and prothrombin time. Unstable patients should also have electrolytes, renal function, and creatine kinase measured. Thrombocytopenia, hypofi brinogenemia, and coagulopathy may develop quickly, but even when severe, rarely represent disseminated intravascular coagulation, as incomplete degradation of fi brinogen by thrombinlike enzymes in venom leads to a poorly formed fi brin clot and coagulation does not occur. 130 , 133 If initial studies and physical exam ination are normal, the patient may have a "dry bite," in which the patient is bitten, but no venom is injected. In such cases, the laboratory studies should be repeated in 6 h, while observation for swelling continues. Patients with mild swelling without other fi ndings should be observed 12 to 24 h to monitor for progression.
Unstable patients should be treated with antivenom. In a stable patient, the decision to treat with antivenom is based on presence of swelling that is progressing, hematotoxicity, or systemic toxicity. Crotalidae Polyvalent Immune Fab (ovine) (CroFab) is the only available antivenom approved for treatment of pit viper envenomation in the United States. When indicated, CroFab should be administered as soon as possible, as it can stop progression of swelling and reverse hematotoxicity. Dosing can be complex and is beyond the scope of this review, but a treatment algorithm is available. 134 In general, an initial dose of four to six vials in stable patients or eight to 12 vials in unstable patients is appropriate. No pediatric dose adjustments are needed. Pregnant women appear to be at increased risk of death following snake bite, and the abortion rate is high, 135 so CroFab should not be withheld due to its class C categorization. It is important to monitor for acute hypersensitivity reactions to CroFab, which are reported in 5.4% of patients. 136 Most reactions are rate-related, and after treatment with antihistamines and resolution of symptoms, CroFab infusion can often be completed at a slower rate.
Patients with severe venom-induced thrombocytopenia and coagulopathy may exhibit minor bleeding from puncture wounds. These laboratory abnormalities do not require administration of blood products. If blood products are given to treat severe hemorrhage, it is critical that antivenom also be administered. Critical platelet, fi brinogen, or prothrombin values alone are not indications for blood products in the setting of pit viper envenomation.
Extremity edema can be impossible to distinguish clinically from compartment syndrome, due to exquisite pain and tenderness, paresthesias and decreased www.chestpubs.org sensation in tense digits, and pulses that are diffi cult to palpate. Nonetheless, true compartment syndrome following North American pit viper envenomation remains very rare. Fasciotomy should not be performed without fi rst measuring and confi rming elevated compartment pressures. Even if pressures moderately exceed 30 mm Hg, some authorities advocate management with further antivenom, elevation, and reassessment in a few hours. If pressures fail to decrease within several hours, fasciotomy may be required. 137 The authors recommend consulting an envenomation specialist if deciding whether to perform fasciotomy.
In the days following the bite, hemorrhagic bullae often expand. Debridement should be performed as it allows for pain relief and evaluation of underlying tissue. If signifi cant necrosis is evident, consultation with a surgeon is recommended as further debridement in the operating room, eventual skin grafting, or even amputation may be necessary. It is important to inform patients from the outset that early antivenom administration does not prevent tissue necrosis or the possibility of loss of a digit.
Another important subacute problem is that of recurrence. In the fi rst 36 h following CroFab administration, patients may develop increased extremity swelling. This is expected when the extremity is dependent, but if swelling increases despite elevation, additional antivenom may be needed. Late hematotoxicity (in which patients may develop severe thrombocytopenia or coagulopathy days after treatment, even if these were not present during the initial treatment) is common and potentially serious. For this reason, all patients treated with CroFab should have platelets and fi brinogen assessed 2 to 4 days and again 5 to 7 days after antivenom. 138 Discharge instructions should advise to monitor for bleeding; avoid aspirin, nonsteroidal antiinfl ammatory drugs (NSAIDs), or antiplatelet and anticoagulant drugs; and avoid surgical or dental procedures for at least 2 weeks following the bite. Management of late or recurrent hematotoxicity should be discussed with an envenomation expert, as retreatment decisions are based on many factors. Patients should also be advised that serum sickness may develop up to 3 weeks following antivenom and is treated with steroids and antihistamines.
Coral snake envenomations differ from those infl icted by pit vipers in that they produce isolated neurotoxicity. Since the venom does not possess cytotoxic or hemotoxic components, local effects do not occur and hematologic studies are normal. Any patient reporting a coral snake bite (except from the Sonoran coral snake) should be observed for 24 h, as puncture wounds are not always visible and neurotoxic effects, including paresthesias, ptosis, weakness, and respiratory failure, may be delayed. Care is supportive, with intubation and mechanical ventilation should symptoms of neurotoxicity, such as diplopia or dysarthria, develop. Rhabdomyolysis should be ruled out. North American Coral Snake Antivenom (Pfi zer; New York, New York ) is no longer produced, and remaining supplies are limited. If available, patients should be treated with a starting dose of four vials at the fi rst sign of envenomation, to prevent progression of symptoms. 139 , 140 Decisions regarding management of snake envenomation are affected by a variety of factors, including species, specifi c venom effects, and availability of appropriate antivenom. Clinicians are advised to contact the poison center (in the United States, 1-800-222-1222) to discuss all cases of snake bite with a specialist.
